Pharma & Healthcare

Global Malaria Vaccines Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Malaria Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Malaria Vaccines.
The Malaria Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Malaria Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Malaria Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline Plc
Sanaria Inc
Nobelpharma Co
Sumaya Biotech
GenVec
Actiza Pharmaceutical Private Limited
AdvaCare Pharma
Ipca Laboratories Ltd
Bliss GVS Pharma Ltd
GeoVax
Pfizer Inc
VLP Therapeutics
OSIVAX
AJANTA PHARMA
Strides Pharma Science Limited
Mylan N.V.
Zydus Cadila
Cipla Inc
Sun Pharmaceutical Industries Ltd
Sanofi
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
Taj Pharmaceuticals Limited
Lupin
Novartis AG
CellFree Sciences
Segment by Type
Pre-Erythrocytic Vaccine
Erythrocytic Vaccine
Multi-antigen Vaccine
Segment by Application
Hospitals
Clinics
Community Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Malaria Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Malaria Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pre-Erythrocytic Vaccine
1.2.3 Erythrocytic Vaccine
1.2.4 Multi-antigen Vaccine
1.3 Market by Application
1.3.1 Global Malaria Vaccines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Community Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Malaria Vaccines Market Perspective (2020-2031)
2.2 Global Malaria Vaccines Growth Trends by Region
2.2.1 Global Malaria Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Malaria Vaccines Historic Market Size by Region (2020-2025)
2.2.3 Malaria Vaccines Forecasted Market Size by Region (2026-2031)
2.3 Malaria Vaccines Market Dynamics
2.3.1 Malaria Vaccines Industry Trends
2.3.2 Malaria Vaccines Market Drivers
2.3.3 Malaria Vaccines Market Challenges
2.3.4 Malaria Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Malaria Vaccines Players by Revenue
3.1.1 Global Top Malaria Vaccines Players by Revenue (2020-2025)
3.1.2 Global Malaria Vaccines Revenue Market Share by Players (2020-2025)
3.2 Global Malaria Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Malaria Vaccines Revenue
3.4 Global Malaria Vaccines Market Concentration Ratio
3.4.1 Global Malaria Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Malaria Vaccines Revenue in 2024
3.5 Global Key Players of Malaria Vaccines Head office and Area Served
3.6 Global Key Players of Malaria Vaccines, Product and Application
3.7 Global Key Players of Malaria Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Malaria Vaccines Breakdown Data by Type
4.1 Global Malaria Vaccines Historic Market Size by Type (2020-2025)
4.2 Global Malaria Vaccines Forecasted Market Size by Type (2026-2031)
5 Malaria Vaccines Breakdown Data by Application
5.1 Global Malaria Vaccines Historic Market Size by Application (2020-2025)
5.2 Global Malaria Vaccines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Malaria Vaccines Market Size (2020-2031)
6.2 North America Malaria Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Malaria Vaccines Market Size by Country (2020-2025)
6.4 North America Malaria Vaccines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Malaria Vaccines Market Size (2020-2031)
7.2 Europe Malaria Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Malaria Vaccines Market Size by Country (2020-2025)
7.4 Europe Malaria Vaccines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Malaria Vaccines Market Size (2020-2031)
8.2 Asia-Pacific Malaria Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Malaria Vaccines Market Size by Region (2020-2025)
8.4 Asia-Pacific Malaria Vaccines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Malaria Vaccines Market Size (2020-2031)
9.2 Latin America Malaria Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Malaria Vaccines Market Size by Country (2020-2025)
9.4 Latin America Malaria Vaccines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Malaria Vaccines Market Size (2020-2031)
10.2 Middle East & Africa Malaria Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Malaria Vaccines Market Size by Country (2020-2025)
10.4 Middle East & Africa Malaria Vaccines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Company Details
11.1.2 GlaxoSmithKline Plc Business Overview
11.1.3 GlaxoSmithKline Plc Malaria Vaccines Introduction
11.1.4 GlaxoSmithKline Plc Revenue in Malaria Vaccines Business (2020-2025)
11.1.5 GlaxoSmithKline Plc Recent Development
11.2 Sanaria Inc
11.2.1 Sanaria Inc Company Details
11.2.2 Sanaria Inc Business Overview
11.2.3 Sanaria Inc Malaria Vaccines Introduction
11.2.4 Sanaria Inc Revenue in Malaria Vaccines Business (2020-2025)
11.2.5 Sanaria Inc Recent Development
11.3 Nobelpharma Co
11.3.1 Nobelpharma Co Company Details
11.3.2 Nobelpharma Co Business Overview
11.3.3 Nobelpharma Co Malaria Vaccines Introduction
11.3.4 Nobelpharma Co Revenue in Malaria Vaccines Business (2020-2025)
11.3.5 Nobelpharma Co Recent Development
11.4 Sumaya Biotech
11.4.1 Sumaya Biotech Company Details
11.4.2 Sumaya Biotech Business Overview
11.4.3 Sumaya Biotech Malaria Vaccines Introduction
11.4.4 Sumaya Biotech Revenue in Malaria Vaccines Business (2020-2025)
11.4.5 Sumaya Biotech Recent Development
11.5 GenVec
11.5.1 GenVec Company Details
11.5.2 GenVec Business Overview
11.5.3 GenVec Malaria Vaccines Introduction
11.5.4 GenVec Revenue in Malaria Vaccines Business (2020-2025)
11.5.5 GenVec Recent Development
11.6 Actiza Pharmaceutical Private Limited
11.6.1 Actiza Pharmaceutical Private Limited Company Details
11.6.2 Actiza Pharmaceutical Private Limited Business Overview
11.6.3 Actiza Pharmaceutical Private Limited Malaria Vaccines Introduction
11.6.4 Actiza Pharmaceutical Private Limited Revenue in Malaria Vaccines Business (2020-2025)
11.6.5 Actiza Pharmaceutical Private Limited Recent Development
11.7 AdvaCare Pharma
11.7.1 AdvaCare Pharma Company Details
11.7.2 AdvaCare Pharma Business Overview
11.7.3 AdvaCare Pharma Malaria Vaccines Introduction
11.7.4 AdvaCare Pharma Revenue in Malaria Vaccines Business (2020-2025)
11.7.5 AdvaCare Pharma Recent Development
11.8 Ipca Laboratories Ltd
11.8.1 Ipca Laboratories Ltd Company Details
11.8.2 Ipca Laboratories Ltd Business Overview
11.8.3 Ipca Laboratories Ltd Malaria Vaccines Introduction
11.8.4 Ipca Laboratories Ltd Revenue in Malaria Vaccines Business (2020-2025)
11.8.5 Ipca Laboratories Ltd Recent Development
11.9 Bliss GVS Pharma Ltd
11.9.1 Bliss GVS Pharma Ltd Company Details
11.9.2 Bliss GVS Pharma Ltd Business Overview
11.9.3 Bliss GVS Pharma Ltd Malaria Vaccines Introduction
11.9.4 Bliss GVS Pharma Ltd Revenue in Malaria Vaccines Business (2020-2025)
11.9.5 Bliss GVS Pharma Ltd Recent Development
11.10 GeoVax
11.10.1 GeoVax Company Details
11.10.2 GeoVax Business Overview
11.10.3 GeoVax Malaria Vaccines Introduction
11.10.4 GeoVax Revenue in Malaria Vaccines Business (2020-2025)
11.10.5 GeoVax Recent Development
11.11 Pfizer Inc
11.11.1 Pfizer Inc Company Details
11.11.2 Pfizer Inc Business Overview
11.11.3 Pfizer Inc Malaria Vaccines Introduction
11.11.4 Pfizer Inc Revenue in Malaria Vaccines Business (2020-2025)
11.11.5 Pfizer Inc Recent Development
11.12 VLP Therapeutics
11.12.1 VLP Therapeutics Company Details
11.12.2 VLP Therapeutics Business Overview
11.12.3 VLP Therapeutics Malaria Vaccines Introduction
11.12.4 VLP Therapeutics Revenue in Malaria Vaccines Business (2020-2025)
11.12.5 VLP Therapeutics Recent Development
11.13 OSIVAX
11.13.1 OSIVAX Company Details
11.13.2 OSIVAX Business Overview
11.13.3 OSIVAX Malaria Vaccines Introduction
11.13.4 OSIVAX Revenue in Malaria Vaccines Business (2020-2025)
11.13.5 OSIVAX Recent Development
11.14 AJANTA PHARMA
11.14.1 AJANTA PHARMA Company Details
11.14.2 AJANTA PHARMA Business Overview
11.14.3 AJANTA PHARMA Malaria Vaccines Introduction
11.14.4 AJANTA PHARMA Revenue in Malaria Vaccines Business (2020-2025)
11.14.5 AJANTA PHARMA Recent Development
11.15 Strides Pharma Science Limited
11.15.1 Strides Pharma Science Limited Company Details
11.15.2 Strides Pharma Science Limited Business Overview
11.15.3 Strides Pharma Science Limited Malaria Vaccines Introduction
11.15.4 Strides Pharma Science Limited Revenue in Malaria Vaccines Business (2020-2025)
11.15.5 Strides Pharma Science Limited Recent Development
11.16 Mylan N.V.
11.16.1 Mylan N.V. Company Details
11.16.2 Mylan N.V. Business Overview
11.16.3 Mylan N.V. Malaria Vaccines Introduction
11.16.4 Mylan N.V. Revenue in Malaria Vaccines Business (2020-2025)
11.16.5 Mylan N.V. Recent Development
11.17 Zydus Cadila
11.17.1 Zydus Cadila Company Details
11.17.2 Zydus Cadila Business Overview
11.17.3 Zydus Cadila Malaria Vaccines Introduction
11.17.4 Zydus Cadila Revenue in Malaria Vaccines Business (2020-2025)
11.17.5 Zydus Cadila Recent Development
11.18 Cipla Inc
11.18.1 Cipla Inc Company Details
11.18.2 Cipla Inc Business Overview
11.18.3 Cipla Inc Malaria Vaccines Introduction
11.18.4 Cipla Inc Revenue in Malaria Vaccines Business (2020-2025)
11.18.5 Cipla Inc Recent Development
11.19 Sun Pharmaceutical Industries Ltd
11.19.1 Sun Pharmaceutical Industries Ltd Company Details
11.19.2 Sun Pharmaceutical Industries Ltd Business Overview
11.19.3 Sun Pharmaceutical Industries Ltd Malaria Vaccines Introduction
11.19.4 Sun Pharmaceutical Industries Ltd Revenue in Malaria Vaccines Business (2020-2025)
11.19.5 Sun Pharmaceutical Industries Ltd Recent Development
11.20 Sanofi
11.20.1 Sanofi Company Details
11.20.2 Sanofi Business Overview
11.20.3 Sanofi Malaria Vaccines Introduction
11.20.4 Sanofi Revenue in Malaria Vaccines Business (2020-2025)
11.20.5 Sanofi Recent Development
11.21 Hikma Pharmaceuticals PLC
11.21.1 Hikma Pharmaceuticals PLC Company Details
11.21.2 Hikma Pharmaceuticals PLC Business Overview
11.21.3 Hikma Pharmaceuticals PLC Malaria Vaccines Introduction
11.21.4 Hikma Pharmaceuticals PLC Revenue in Malaria Vaccines Business (2020-2025)
11.21.5 Hikma Pharmaceuticals PLC Recent Development
11.22 Amneal Pharmaceuticals LLC
11.22.1 Amneal Pharmaceuticals LLC Company Details
11.22.2 Amneal Pharmaceuticals LLC Business Overview
11.22.3 Amneal Pharmaceuticals LLC Malaria Vaccines Introduction
11.22.4 Amneal Pharmaceuticals LLC Revenue in Malaria Vaccines Business (2020-2025)
11.22.5 Amneal Pharmaceuticals LLC Recent Development
11.23 Taj Pharmaceuticals Limited
11.23.1 Taj Pharmaceuticals Limited Company Details
11.23.2 Taj Pharmaceuticals Limited Business Overview
11.23.3 Taj Pharmaceuticals Limited Malaria Vaccines Introduction
11.23.4 Taj Pharmaceuticals Limited Revenue in Malaria Vaccines Business (2020-2025)
11.23.5 Taj Pharmaceuticals Limited Recent Development
11.24 Lupin
11.24.1 Lupin Company Details
11.24.2 Lupin Business Overview
11.24.3 Lupin Malaria Vaccines Introduction
11.24.4 Lupin Revenue in Malaria Vaccines Business (2020-2025)
11.24.5 Lupin Recent Development
11.25 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Malaria Vaccines Introduction
11.25.4 Novartis AG Revenue in Malaria Vaccines Business (2020-2025)
11.25.5 Novartis AG Recent Development
11.26 CellFree Sciences
11.26.1 CellFree Sciences Company Details
11.26.2 CellFree Sciences Business Overview
11.26.3 CellFree Sciences Malaria Vaccines Introduction
11.26.4 CellFree Sciences Revenue in Malaria Vaccines Business (2020-2025)
11.26.5 CellFree Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Malaria Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pre-Erythrocytic Vaccine
Table 3. Key Players of Erythrocytic Vaccine
Table 4. Key Players of Multi-antigen Vaccine
Table 5. Global Malaria Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Malaria Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Malaria Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Malaria Vaccines Market Share by Region (2020-2025)
Table 9. Global Malaria Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Malaria Vaccines Market Share by Region (2026-2031)
Table 11. Malaria Vaccines Market Trends
Table 12. Malaria Vaccines Market Drivers
Table 13. Malaria Vaccines Market Challenges
Table 14. Malaria Vaccines Market Restraints
Table 15. Global Malaria Vaccines Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Malaria Vaccines Market Share by Players (2020-2025)
Table 17. Global Top Malaria Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2024)
Table 18. Ranking of Global Top Malaria Vaccines Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Malaria Vaccines Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Malaria Vaccines, Headquarters and Area Served
Table 21. Global Key Players of Malaria Vaccines, Product and Application
Table 22. Global Key Players of Malaria Vaccines, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Malaria Vaccines Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Malaria Vaccines Revenue Market Share by Type (2020-2025)
Table 26. Global Malaria Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Malaria Vaccines Revenue Market Share by Type (2026-2031)
Table 28. Global Malaria Vaccines Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Malaria Vaccines Revenue Market Share by Application (2020-2025)
Table 30. Global Malaria Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Malaria Vaccines Revenue Market Share by Application (2026-2031)
Table 32. North America Malaria Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Malaria Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Malaria Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Malaria Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Malaria Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Malaria Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Malaria Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Malaria Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Malaria Vaccines Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Malaria Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Malaria Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Malaria Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Malaria Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Malaria Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Malaria Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 47. GlaxoSmithKline Plc Company Details
Table 48. GlaxoSmithKline Plc Business Overview
Table 49. GlaxoSmithKline Plc Malaria Vaccines Product
Table 50. GlaxoSmithKline Plc Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 51. GlaxoSmithKline Plc Recent Development
Table 52. Sanaria Inc Company Details
Table 53. Sanaria Inc Business Overview
Table 54. Sanaria Inc Malaria Vaccines Product
Table 55. Sanaria Inc Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 56. Sanaria Inc Recent Development
Table 57. Nobelpharma Co Company Details
Table 58. Nobelpharma Co Business Overview
Table 59. Nobelpharma Co Malaria Vaccines Product
Table 60. Nobelpharma Co Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 61. Nobelpharma Co Recent Development
Table 62. Sumaya Biotech Company Details
Table 63. Sumaya Biotech Business Overview
Table 64. Sumaya Biotech Malaria Vaccines Product
Table 65. Sumaya Biotech Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 66. Sumaya Biotech Recent Development
Table 67. GenVec Company Details
Table 68. GenVec Business Overview
Table 69. GenVec Malaria Vaccines Product
Table 70. GenVec Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 71. GenVec Recent Development
Table 72. Actiza Pharmaceutical Private Limited Company Details
Table 73. Actiza Pharmaceutical Private Limited Business Overview
Table 74. Actiza Pharmaceutical Private Limited Malaria Vaccines Product
Table 75. Actiza Pharmaceutical Private Limited Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 76. Actiza Pharmaceutical Private Limited Recent Development
Table 77. AdvaCare Pharma Company Details
Table 78. AdvaCare Pharma Business Overview
Table 79. AdvaCare Pharma Malaria Vaccines Product
Table 80. AdvaCare Pharma Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 81. AdvaCare Pharma Recent Development
Table 82. Ipca Laboratories Ltd Company Details
Table 83. Ipca Laboratories Ltd Business Overview
Table 84. Ipca Laboratories Ltd Malaria Vaccines Product
Table 85. Ipca Laboratories Ltd Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 86. Ipca Laboratories Ltd Recent Development
Table 87. Bliss GVS Pharma Ltd Company Details
Table 88. Bliss GVS Pharma Ltd Business Overview
Table 89. Bliss GVS Pharma Ltd Malaria Vaccines Product
Table 90. Bliss GVS Pharma Ltd Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 91. Bliss GVS Pharma Ltd Recent Development
Table 92. GeoVax Company Details
Table 93. GeoVax Business Overview
Table 94. GeoVax Malaria Vaccines Product
Table 95. GeoVax Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 96. GeoVax Recent Development
Table 97. Pfizer Inc Company Details
Table 98. Pfizer Inc Business Overview
Table 99. Pfizer Inc Malaria Vaccines Product
Table 100. Pfizer Inc Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 101. Pfizer Inc Recent Development
Table 102. VLP Therapeutics Company Details
Table 103. VLP Therapeutics Business Overview
Table 104. VLP Therapeutics Malaria Vaccines Product
Table 105. VLP Therapeutics Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 106. VLP Therapeutics Recent Development
Table 107. OSIVAX Company Details
Table 108. OSIVAX Business Overview
Table 109. OSIVAX Malaria Vaccines Product
Table 110. OSIVAX Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 111. OSIVAX Recent Development
Table 112. AJANTA PHARMA Company Details
Table 113. AJANTA PHARMA Business Overview
Table 114. AJANTA PHARMA Malaria Vaccines Product
Table 115. AJANTA PHARMA Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 116. AJANTA PHARMA Recent Development
Table 117. Strides Pharma Science Limited Company Details
Table 118. Strides Pharma Science Limited Business Overview
Table 119. Strides Pharma Science Limited Malaria Vaccines Product
Table 120. Strides Pharma Science Limited Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 121. Strides Pharma Science Limited Recent Development
Table 122. Mylan N.V. Company Details
Table 123. Mylan N.V. Business Overview
Table 124. Mylan N.V. Malaria Vaccines Product
Table 125. Mylan N.V. Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 126. Mylan N.V. Recent Development
Table 127. Zydus Cadila Company Details
Table 128. Zydus Cadila Business Overview
Table 129. Zydus Cadila Malaria Vaccines Product
Table 130. Zydus Cadila Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 131. Zydus Cadila Recent Development
Table 132. Cipla Inc Company Details
Table 133. Cipla Inc Business Overview
Table 134. Cipla Inc Malaria Vaccines Product
Table 135. Cipla Inc Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 136. Cipla Inc Recent Development
Table 137. Sun Pharmaceutical Industries Ltd Company Details
Table 138. Sun Pharmaceutical Industries Ltd Business Overview
Table 139. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product
Table 140. Sun Pharmaceutical Industries Ltd Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 141. Sun Pharmaceutical Industries Ltd Recent Development
Table 142. Sanofi Company Details
Table 143. Sanofi Business Overview
Table 144. Sanofi Malaria Vaccines Product
Table 145. Sanofi Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 146. Sanofi Recent Development
Table 147. Hikma Pharmaceuticals PLC Company Details
Table 148. Hikma Pharmaceuticals PLC Business Overview
Table 149. Hikma Pharmaceuticals PLC Malaria Vaccines Product
Table 150. Hikma Pharmaceuticals PLC Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 151. Hikma Pharmaceuticals PLC Recent Development
Table 152. Amneal Pharmaceuticals LLC Company Details
Table 153. Amneal Pharmaceuticals LLC Business Overview
Table 154. Amneal Pharmaceuticals LLC Malaria Vaccines Product
Table 155. Amneal Pharmaceuticals LLC Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 156. Amneal Pharmaceuticals LLC Recent Development
Table 157. Taj Pharmaceuticals Limited Company Details
Table 158. Taj Pharmaceuticals Limited Business Overview
Table 159. Taj Pharmaceuticals Limited Malaria Vaccines Product
Table 160. Taj Pharmaceuticals Limited Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 161. Taj Pharmaceuticals Limited Recent Development
Table 162. Lupin Company Details
Table 163. Lupin Business Overview
Table 164. Lupin Malaria Vaccines Product
Table 165. Lupin Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 166. Lupin Recent Development
Table 167. Novartis AG Company Details
Table 168. Novartis AG Business Overview
Table 169. Novartis AG Malaria Vaccines Product
Table 170. Novartis AG Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 171. Novartis AG Recent Development
Table 172. CellFree Sciences Company Details
Table 173. CellFree Sciences Business Overview
Table 174. CellFree Sciences Malaria Vaccines Product
Table 175. CellFree Sciences Revenue in Malaria Vaccines Business (2020-2025) & (US$ Million)
Table 176. CellFree Sciences Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
Table 180. Authors List of This Report


List of Figures
Figure 1. Malaria Vaccines Picture
Figure 2. Global Malaria Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Malaria Vaccines Market Share by Type: 2024 VS 2031
Figure 4. Pre-Erythrocytic Vaccine Features
Figure 5. Erythrocytic Vaccine Features
Figure 6. Multi-antigen Vaccine Features
Figure 7. Global Malaria Vaccines Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Malaria Vaccines Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Community Centers Case Studies
Figure 12. Malaria Vaccines Report Years Considered
Figure 13. Global Malaria Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Malaria Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Malaria Vaccines Market Share by Region: 2024 VS 2031
Figure 16. Global Malaria Vaccines Market Share by Players in 2024
Figure 17. Global Top Malaria Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Vaccines as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Malaria Vaccines Revenue in 2024
Figure 19. North America Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Malaria Vaccines Market Share by Country (2020-2031)
Figure 21. United States Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Malaria Vaccines Market Share by Country (2020-2031)
Figure 25. Germany Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Malaria Vaccines Market Share by Region (2020-2031)
Figure 33. China Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Malaria Vaccines Market Share by Country (2020-2031)
Figure 41. Mexico Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Malaria Vaccines Market Share by Country (2020-2031)
Figure 45. Turkey Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Malaria Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. GlaxoSmithKline Plc Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 49. Sanaria Inc Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 50. Nobelpharma Co Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 51. Sumaya Biotech Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 52. GenVec Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 53. Actiza Pharmaceutical Private Limited Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 54. AdvaCare Pharma Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 55. Ipca Laboratories Ltd Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 56. Bliss GVS Pharma Ltd Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 57. GeoVax Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 58. Pfizer Inc Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 59. VLP Therapeutics Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 60. OSIVAX Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 61. AJANTA PHARMA Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 62. Strides Pharma Science Limited Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 63. Mylan N.V. Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 64. Zydus Cadila Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 65. Cipla Inc Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 66. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 67. Sanofi Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 68. Hikma Pharmaceuticals PLC Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 69. Amneal Pharmaceuticals LLC Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 70. Taj Pharmaceuticals Limited Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 71. Lupin Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 72. Novartis AG Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 73. CellFree Sciences Revenue Growth Rate in Malaria Vaccines Business (2020-2025)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies